To OTC Journal Members:
 

Amnis Systems (OTC BB: AMNM)- Bell Canada Loves Amnis' Technology

When I kicked off our first edition on Amnis Systems back on June 3rd, I placed a price target on the stock of $.15 over the ensuing 60 days. On July 10th and 11th the stock achieved the $.15 mark, but was temporarily repelled. It went on to complete a round trip back to $.085.

Oftentimes, as companies begin a rebound phase, a stock must make several attempts at higher levels before breaking through. The stock is setting up a new trendline as shown in the chart, having broken down through the previous trend line. Nevertheless, the uptrend remains intact, and it has pulled back to a nearly perfect 50% retracement of the gains made since the rebound phase began.

Another attempt at the $.15 level is probably in the cards now, which undoubtedly started today when the company announced some of the details surrounding the robotic surgery that was performed remotely over a Bell Canada network using Amnis streaming technology.

The surgery was performed by Ontario's  Dr. Nehran Anvari, in Hamilton's St Joseph's Healthcare. The patient was hundreds of miles away at North Bay General Hospital. According to the press release the doctor's performed: "a laparoscopic Nissen fundoplication (anti-reflux) surgery over Bell Canada's VPNe network. Dr. Anvari used controls that manipulated robotic arms and surgical instruments that were several hundred miles away all the while watching through a television monitor which was connected to the Amnis NAC-4000 MPEG-2 receiver. The surgeons demanded high quality video with latency as close to real time as possible."

As I write this edition, the stock has already traded over 4 million shares and broken through $.09. I still believe over the longer term the stock could find its way back to the $.25 level if product sales accelerate.

Conclusion- if you missed the first 100% move in this stock from $.07 to $.15, you might have another shot. Click Here to read the full text of the press release.
 

VirTra Systems (OTC BB: VTSI) Rolls Out Fixed 360° Version of Training Simulator

Just prior to the close today, VirTra Systems, my latest idea in the microcap arena, announced that their new "Judgemental Use Of Force" 360° simulator has now been introduced and is ready for sale. 

This event represents the entry into a new and burgeoning market for VirTra Systems. The company already has a foothold in the promotional market through contracts with Pennzoil, Red Baron, Buick, and Pepsi. Homeland Security and military applications represent a new market for VirTra Systems, which has me very excited about the prospects for this company.

No other simulator on the market today matches VirTra Systems for creating a full, 360° high stress training experience. This product uses multi array projection instead of a head set. The trainee uses the actual weapon he or she would use in a real life situation, not a plastic video game type appliance. 

The Homeland Security budget has expanded to $37.7 billion. Earlier today, lower Manhattan was shut down as a City Councilman was reported to have been shot at City Hall. These types of events tend to fuel demand for trained security officers, and Virtra Systems has products to fill the demand. Typically, governmental budgets are planned in the summer and fall, and contracts are awarded in the September to December time frame for the coming fiscal year.

I believe there is plenty of upside from the ridiculously low level at which this stock trades. Based on today's levels, the market is only valuing the company at about $4 million. This stock has also pulled back into the middle of its trading range, offering an ideal, lower risk entry level.

If this company begins announcing sales of the simulators to any kind of security agency, be it military or non-military, I suspect the stock will grow legs and run up the charts. The trick is to own it before it happens. 

The surge you see in July was on heavy volume. The ensuing pullback has been on light volume, suggesting it could turn back up quite easily. I don't believe this stock will hang around in the $.10 area for long, especially if contracts start rolling in.
 
 
 

Here is the complete text of today's press release for your review:
 

Click Here to view our compensation on every company we have ever covered, or visit the following web address:  http://www.otcjournal.com/disclaimer.html for our full profiles and http://www.otcjournal.com/trading-alerts/disclaimer.html for Trading Alerts. MarketByte LLC has been paid a fee of $25,000 in cash and one million newly issued restricted shares by Virtra Systems for coverage of the company.  MarketBtye LLC has been paid of fee of $25,000 in cash and 2 million newly issued restricted shares by Amnis for coverage of the company.

All statements and expressions are the sole  opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the newsletter is neither an offer nor solicitation to buy or sell any securities  mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.

The editor, members of the editor's family, and/or entities with which they are affiliated, are forbidden by company policy to own, buy, sell or otherwise trade stock for their own benefit in the companies who appear in the publication unless specifically disclosed in the newsletter.

The profiles, critiques, and other editorial content of the OTCjournal.com may contain forward-looking statements relating to the expected capabilities of the companies mentioned herein.

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN  SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN  CONSENT OF THE EDITORS OF OTCjournal.com.

We encourage our readers to invest carefully and read the investor information available at the web sites of  the Securities and Exchange Commission ("SEC") at http://www.sec.govand/or the National Association of Securities Dealers ("NASD") at http://www.nasd.com. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at  http://www.sec.gov/consumer/cyberfr.htm. Disclaimer ID:$subst('Recip.userid') Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site.